397 related articles for article (PubMed ID: 34516843)
21. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
22. Loss of prdm1a accelerates melanoma onset and progression.
Iwanaga R; Truong BT; Hsu JY; Lambert KA; Vyas R; Orlicky D; Shellman YG; Tan AC; Ceol C; Artinger KB
Mol Carcinog; 2020 Sep; 59(9):1052-1063. PubMed ID: 32562448
[TBL] [Abstract][Full Text] [Related]
23. Nucleotide stress responses in neural crest cell fate and melanoma.
Sporrij A; Zon LI
Cell Cycle; 2021 Aug; 20(15):1455-1467. PubMed ID: 34281491
[TBL] [Abstract][Full Text] [Related]
24. Ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
Kanazawa K; Kishimoto K; Nomura M; Kurosawa K; Kato H; Inoue Y; Miura K; Fukui K; Yamashita Y; Sato I; Tsuji H; Watanabe T; Tanaka T; Yasuda J; Tanuma N; Shima H
Cancer Sci; 2021 Jun; 112(6):2233-2244. PubMed ID: 33743547
[TBL] [Abstract][Full Text] [Related]
25. Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase.
Potterf SB; Mollaaghababa R; Hou L; Southard-Smith EM; Hornyak TJ; Arnheiter H; Pavan WJ
Dev Biol; 2001 Sep; 237(2):245-57. PubMed ID: 11543611
[TBL] [Abstract][Full Text] [Related]
26. [Epigenetic regulation of gene expression in malignant melanoma].
Laurette P; Koludrovic D; Coassolo S; Davidson I
Biol Aujourdhui; 2016; 210(4):283-295. PubMed ID: 28327285
[TBL] [Abstract][Full Text] [Related]
27. A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.
Lister JA; Capper A; Zeng Z; Mathers ME; Richardson J; Paranthaman K; Jackson IJ; Elizabeth Patton E
J Invest Dermatol; 2014 Jan; 134(1):133-140. PubMed ID: 23831555
[TBL] [Abstract][Full Text] [Related]
28. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
Wan L; Chen M; Cao J; Dai X; Yin Q; Zhang J; Song SJ; Lu Y; Liu J; Inuzuka H; Katon JM; Berry K; Fung J; Ng C; Liu P; Song MS; Xue L; Bronson RT; Kirschner MW; Cui R; Pandolfi PP; Wei W
Cancer Discov; 2017 Apr; 7(4):424-441. PubMed ID: 28174173
[TBL] [Abstract][Full Text] [Related]
29. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.
Ramgolam K; Lauriol J; Lalou C; Lauden L; Michel L; de la Grange P; Khatib AM; Aoudjit F; Charron D; Alcaide-Loridan C; Al-Daccak R
PLoS One; 2011 Apr; 6(4):e18784. PubMed ID: 21526207
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional profile and chromatin accessibility in zebrafish melanocytes and melanoma tumors.
Kramer ET; Godoy PM; Kaufman CK
G3 (Bethesda); 2022 Jan; 12(1):. PubMed ID: 34791221
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
Boyd SC; Mijatov B; Pupo GM; Tran SL; Gowrishankar K; Shaw HM; Goding CR; Scolyer RA; Mann GJ; Kefford RF; Rizos H; Becker TM
J Invest Dermatol; 2013 May; 133(5):1269-77. PubMed ID: 23190890
[TBL] [Abstract][Full Text] [Related]
32. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.
Mehrotra A; Saladi SV; Trivedi AR; Aras S; Qi H; Jayanthy A; Setaluri V; de la Serna IL
Arch Biochem Biophys; 2014 Dec; 563():125-35. PubMed ID: 25026375
[TBL] [Abstract][Full Text] [Related]
34. A systems biology approach uncovers the core gene regulatory network governing iridophore fate choice from the neural crest.
Petratou K; Subkhankulova T; Lister JA; Rocco A; Schwetlick H; Kelsh RN
PLoS Genet; 2018 Oct; 14(10):e1007402. PubMed ID: 30286071
[TBL] [Abstract][Full Text] [Related]
35. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
Haq R; Yokoyama S; Hawryluk EB; Jönsson GB; Frederick DT; McHenry K; Porter D; Tran TN; Love KT; Langer R; Anderson DG; Garraway LA; Duncan LM; Morton DL; Hoon DS; Wargo JA; Song JS; Fisher DE
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4321-6. PubMed ID: 23447565
[TBL] [Abstract][Full Text] [Related]
36. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
[TBL] [Abstract][Full Text] [Related]
38. prdm1a Regulates sox10 and islet1 in the development of neural crest and Rohon-Beard sensory neurons.
Olesnicky E; Hernandez-Lagunas L; Artinger KB
Genesis; 2010 Nov; 48(11):656-66. PubMed ID: 20836130
[TBL] [Abstract][Full Text] [Related]
39. Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes.
Köhler C; Nittner D; Rambow F; Radaelli E; Stanchi F; Vandamme N; Baggiolini A; Sommer L; Berx G; van den Oord JJ; Gerhardt H; Blanpain C; Marine JC
Cell Stem Cell; 2017 Nov; 21(5):679-693.e6. PubMed ID: 29033351
[TBL] [Abstract][Full Text] [Related]
40. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
